Advertisement

Topics

Progressing patient-derived material a 'key strategic focus,' says Evotec CEO

13:27 EDT 8 Aug 2017 | Outsourcing-Pharma

Original Article: Progressing patient-derived material a 'key strategic focus,' says Evotec CEO

NEXT ARTICLE

More From BioPortfolio on "Progressing patient-derived material a 'key strategic focus,' says Evotec CEO"

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...